New uracil analog U-332 is an inhibitor of NF-κB in 5-fluorouracil-resistant human leukemia HL-60 cell line.

Saved in:
Bibliographic Details
Title: New uracil analog U-332 is an inhibitor of NF-κB in 5-fluorouracil-resistant human leukemia HL-60 cell line.
Authors: Długosz-Pokorska A; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland., Pięta M; Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Lodz, Poland., Kędzia J; Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Lodz, Poland., Janecki T; Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Lodz, Poland., Janecka A; Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland. anna.janecka@umed.lodz.pl.
Source: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2020 Mar 02; Vol. 21 (1), pp. 18. Date of Electronic Publication: 2020 Mar 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511 (Electronic) Linking ISSN: 20506511 NLM ISO Abbreviation: BMC Pharmacol Toxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2050-6511
DOI:10.1186/s40360-020-0397-4